Home

Laboratory tests

Laboratory tests can compliment symptom reports to provide a more complete clinical picture of patients' progress on the Marshall Protocol (MP).

Patients who progress on the MP typically experience immunopathology. Immunopathology is caused largely by cytokinesAny of various protein molecules secreted by cells of the immune system that serve to regulate the immune system. generated by the immune response and endotoxins released from dying bacteria. Occasionally, immunopathology will consist of an abnormal lab value such as elevated creatinine, elevated liver enzymes, or low white blood count. This is due to the occurrence of subclinical bacterial inflammation that has been revealed by olmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. 's (Benicar) activation of the immune system.

The levels of the two most important vitamin D metabolites, 25-DThe vitamin D metabolite widely (and erroneously) considered best indicator of vitamin D "deficiency." Inactivates the Vitamin D Nuclear Receptor. Produced by hydroxylation of vitamin D3 in the liver. and 1,25-DPrimary biologically active vitamin D hormone. Activates the vitamin D nuclear receptor. Produced by hydroxylation of 25-D. Also known as 1,25-dihydroxycholecalciferol, 1,25-hydroxyvitamin D and calcitirol., can be interpreted using the Vitamin D Metabolite Calculator. A periodic assessment of a patient's serum 25-D level, which is inversely correlated with immune function, is strongly recommended – especially as it declines below 20 ng/ml. Testing 1,25-D as a measure of inflammation is only useful before taking olmesartan.

Baseline inflammatory marker tests such as a complete blood count (CBC) along with a comprehensive metabolic panel (CMP) should also be ordered prior to introducing olmesartan to provide the best possible measure of chronic inflammation in the patient prior to treatment.

Under many circumstances, some laboratory tests can be considered non-essential. Patient and doctor should discuss the decision to perform these tests based on the individual patient's clinical picture and any economic concerns. Every test should be interpreted by the physician in the relevant clinical context.

Vitamin D metabolism

Short of trying the Marshall Protocol itself (i.e. a therapeutic probeA brief trial of the Marshall Protocol to see if it will generate an immunopathological response. The "gold standard" for testing whether a patient is a good candidate for the MP.), the most valid way to determine if the MP is applicable to a patient is by measuring serum levels of two key vitamin D metabolites: 25-D and 1,25-D. 25-D is a measure of innate immune function with higher levels suggesting active immunosuppression. 1,25-D is a measure of inflammation.

Contextual interpretation of a patient's 25-D and 1,25-D results are available using the vitamin D metabolite calculator. When testing the vitamin D metabolites, all relevant instructions, including the freezing of samples, should be closely followed.

It is also possible to test 25-D at home with a home test kit.

Kidney (renal) function

Main article: Kidney (renal) function

Most patients on the MP experience temporary but well-defined increases in various markers of disease state and inflammation, consistent with an immunopathological response. Results of blood tests for kidney function can generate considerable angst for Marshall Protocol patients and their medical providers. Out of genuine concern for their patients, some physicians consider withholding prescription of olmesartan. Experiences on the MP show that this concern may be mostly unfounded. And that the aberrant test values are to be expected from the nature of the MP treatment.

Doctors may want to assess kidney function by testing creatinine clearance test or BUN and measure other indicators specific to each patient for a baseline and retest as appropriate. Due to immunopathology, lab these values may become temporarily abnormal until the inflammation resolves.

→ Read more...

Example of immunopathology – Patients on the Marshall Protocol tend to experience temporary increase in several antibody titers, and a decline in latter stages of treatment.1)

Other tests

  • complete blood count (CBC) – A test panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood. Widely used for regular checkups.
  • antibodies – Expected to increase with immunopathology. (See right.)
  • blood pressure – hypotension and dizziness can be exacerbated during recovery on the MP
  • bone density – The primary tool for measuring bone density is a DEXA (also known as DXA) scan. DEXA may provide evidence that treatment is reversing Th1 diseaseAny of the chronic inflammatory diseases caused by bacterial pathogens. related bone loss such as the kind observed in osteoporosis and osteopenia. Results usually do not change course of treatment.
  • colonoscopy – Endoscopic examination of the colon and the distal part of the small bowel with a small camera on a flexible tube. May provide reassurance when fearful of malignancy, but can expose patient to greater infection due to difficulties in sterilizing equipment. Results usually do not change course of treatment.
  • imaging tests – Includes x-ray, magnetic resonance imaging (MRI), and computed tomography (CT Scan). Significant level of interpretation required to determine meaning of resulting image. Exposes patient with chronic inflammation to additional radiation, possibly increasing the risk of cancer. Results tend not to change course of treatment.
  • lung function – For patients with lung involvement, tests of pulmonary function may temporarily decline on the MP, but are expected to improve over time.
  • thyroid function – It is common for patients suffering from chronic diseases to have low levels of thyroid hormones.

How to obtain lab results

Patients should remember they are the most important member of their health care team. Making sure you know what is in your medical records means that they are able to follow-up on questions and in some cases, verify accuracy. A doctor's office personnel can read you the exact numbers with measurements over the phone but patients should get a printed copy of all lab results.

Patients may need to sign a release of information form. Call the clinic's “Release of Information Office” or Medical Records to find out what their procedure is to obtain medical records. A patient should be able to do this all via the phone and mail. Once a signed release form is on file, patients can often just call them and have them mail you copies of the doctor's clinic note and test results after each visit.

It is best to always ask for copies of your lab reports, x-rays reports, clinic notes, etc. A proactive patient knows exactly what is in his/her medical record.

Excessive testing

Patients should be wary of excessive testing and procedures.

In the face of uncertainty and ambiguity, a clinician's natural response might be to order a battery of tests. After all, the more information clinicians obtain, the more confidence they have in the validity of their diagnoses, even when such confidence may not be justified on the basis of the information obtained.

In his paper, “Our stubborn quest for diagnostic certainty: a cause of excessive testing,” JP Kassirer writes:

Absolute certainty in diagnosis is unattainable, no matter how much information we gather, how many observations we make, or how many tests we perform. Our task is not to attain certainty, but rather to reduce the level of diagnostic uncertainty enough to make optimal therapeutic decisions…. We continue to test excessively, partly because of our discomfort with uncertainty.

Jerome Kassirer, MD 3)

In practice, as one approaches diagnostic certainty the useful information returned by diagnostic tests and observations approaches zero.4)

A 2011 article in the Daily Beast showed how some common tests and procedures may do more harm than good.

1)
Proal, A.D. (2009). “Antibodies and infection in the era of metagenome” at 1st International Congress of Antibodies (Beijing).
2)
Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM. 2003 Dec;96(12):927-34. doi: 10.1093/qjmed/hcg150.
[PMID: 14631060] [DOI: 10.1093/qjmed/hcg150]
3)
Kassirer JP. Our stubborn quest for diagnostic certainty. A cause of excessive testing. N Engl J Med. 1989 Jun 1;320(22):1489-91. doi: 10.1056/NEJM198906013202211.
[PMID: 2497349] [DOI: 10.1056/NEJM198906013202211]
4)
Johnson HA. Diminishing returns on the road to diagnostic certainty. JAMA. 1991 May 1;265(17):2229-31.
[PMID: 1901611]
home/tests.txt · Last modified: by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.